News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Namouni Fouad
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,769 shares
@ $48.06, valued at
$181.1k
|
|
| 03/08/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,885 shares
@ $45.72, valued at
$86.2k
Sold 63 shares
@ $44.36, valued at
$2.8k
|
|
| 03/03/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $43.15, valued at
$1.3M
|
|
| 10/05/2022 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,477 shares
@ $67.3, valued at
$234k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Namouni Fouad (President, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 13,062 shares
@ $0
Granted 26,125 options to buy
@ $100.13, valued at
$2.6M
|
|
| 10/05/2020 |
4
| Namouni Fouad (President, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 32,500 shares
@ $0
Granted 65,000 options to buy
@ $93.93, valued at
$6.1M
|
|
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|